Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Marimed (MRMD) Non Operating Investment Income (2016 - 2022)

Marimed (MRMD) has disclosed Non Operating Investment Income for 7 consecutive years, with $48000.0 as the latest value for Q1 2022.

  • Quarterly Non Operating Investment Income rose 206.67% to $48000.0 in Q1 2022 from the year-ago period, while the trailing twelve-month figure was -$1.0 million through Mar 2022, down 446.63% year-over-year, with the annual reading at -$1.1 million for FY2021, 216.5% down from the prior year.
  • Non Operating Investment Income for Q1 2022 was $48000.0 at Marimed, up from -$169203.0 in the prior quarter.
  • The five-year high for Non Operating Investment Income was $354534.0 in Q4 2020, with the low at -$687002.0 in Q1 2020.
  • Average Non Operating Investment Income over 3 years is -$156451.8, with a median of -$169203.0 recorded in 2021.
  • The sharpest move saw Non Operating Investment Income crashed 340.19% in 2021, then surged 206.67% in 2022.
  • Over 3 years, Non Operating Investment Income stood at $354534.0 in 2020, then crashed by 147.73% to -$169203.0 in 2021, then soared by 128.37% to $48000.0 in 2022.
  • According to Business Quant data, Non Operating Investment Income over the past three periods came in at $48000.0, -$169203.0, and -$522106.0 for Q1 2022, Q4 2021, and Q3 2021 respectively.